BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• ZanthoSyn From Cardax Now Available at 3,000+ GNC Corporate Stores in the U.S.

  This nation-wide availability builds on Cardax’s previously announced national purchase order and mutual exclusivity agreement with GNC.

  December 7, 2017

   · 

  4 min read
• Drug Development

  Kerastem Reports Successful U.S. Phase II Hair Growth Clinical Trial Results

  The Kerastem therapy is a one-time treatment that utilizes adipose derived regenerative cells combined with purified fat delivered to the affected area of scalp.

  December 7, 2017

   · 

  2 min read
• Genetown

  Lumicell Presents Phase II Clinical Data Showing LUM System Provided Complete and Immediate Detection of Residual Cancer in Tumor Cavity During Lumpectomy Surgery

  The Phase 2 data were presented at the 2017 San Antonio Breast Cancer Symposium (SABCS) being held December 5-9, 2017 in San Antonio, Texas.

  December 7, 2017

   · 

  4 min read
• BioForest

  Seattle Genetics Presents Updated Phase I Data for Ladiratuzumab Vedotin (SGN-LIV1A) in Patients With Triple Negative Breast Cancer at 2017 San Antonio Breast Cancer Symposium

  Seattle Genetics announced updated data from an ongoing phase 1 clinical trial evaluating ladiratuzumab vedotin in patients with metastatic triple negative breast cancer (TNBC) at the 2017 San Antonio Breast Cancer Symposium (SABCS), taking place December 5-9, 2017.

  December 7, 2017

   · 

  7 min read
• Business

  bluebird bio and TC BioPharm Announce Strategic Collaboration to Research and Develop Gamma Delta CAR T Cell Product Candidates for Cancer Immunotherapy

  Under the terms of the agreement, bluebird bio and TCB will collaborate to discover and develop CAR-engineered gamma delta T cells for cancer targets and indications.

  December 7, 2017

   · 

  7 min read
• BioCapital

  The Emmes Corporation Release: New Research Links Umbilical Cord Blood to Motor Function Improvement in Children with Cerebral Palsy

  The research demonstrated improvements in motor function a year after the injection of a high dose of stem cells from a child’s own cord blood.

  December 7, 2017

   · 

  2 min read
• Biotech Bay

  Revance Announces Pricing of Public Offering of 5,338,709 shares of Common Stock

  Revance announced the pricing of an underwritten public offering of 5,338,709 shares of its common stock at a price to the public of $31.00 per share.

  December 7, 2017

   · 

  4 min read
• Drug Development

  Concentric Analgesics Receives FDA Fast Track Designation for CA-008 for Post-Surgical Pain

  CA-008 is a proprietary water-soluble prodrug that converts into capsaicin, a potent TRPV-1 agonist.

  December 7, 2017

   · 

  3 min read
• 

  Business

  Bay Area’s XOMA Snags $240M Deal With Newly-Transformed Rezolute

  Rezolute is responsible for all development, regulatory, manufacturing and commercialization activities under the license.

  December 7, 2017

   · 

  6 min read
• Pharm Country

  iCAD Announces Study Demonstrating Economic and Health Benefits of Intraoperative Radiation Therapy (IORT) for Early-Stage Breast Cancer Treatment

  The analysis demonstrated that IORT could result in direct cost savings for the U.S. healthcare system of more than $630 million over the lifetime of patients diagnosed annually with early-stage breast cancer.

  December 7, 2017

   · 

  6 min read